Skip to main content

Online First

Online First
FDA Updates
Jakafi a New Treatment Option for Chronic Graft-Versus-Host Disease
Read More
Online First
FDA Updates
Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer
Read More
Online First
FDA Updates
Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma
Read More
Online First
FDA Updates
Jemperli Another Therapy Approved for Patients with dMMR Recurrent or Advanced Solid Tumors
Read More
Online First
FDA Updates
Lenvima plus Keytruda a New Combination Approved for Advanced Renal-Cell Carcinoma
Read More
Online First
Case Reports, Leukemia
Successful Treatment of Chronic Myeloid Leukemia with Low-Dose Nilotinib
Eric Haigh, BS, Kamran Darabi, MD
Read More
Online First
Original Research
Florida Pharmacy Students’ Perspectives on Careers in Oncology
Paige May, PharmD, BCOP, Joseph Ladd, PharmD
Read More
Online First
FDA Updates, Venetoclax
Venclexta (Venetoclax) First BCL-2 Inhibitor Approved for High-Risk Relapsed Chronic Lymphocytic Leukemia
Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
Online First
Challenges in ALK-Positive NSCLC Management
Meg Barbor, MPH
Read More
Online First
Lowering the High Cost of USP 800 Compliance
Meg Barbor, MPH
Read More
Page 6 of 13
Results 51 - 60 of 129